Perth-based Avita Medical has struck a distribution deal in Iran for its spray on skin products for the treatment of burns, wounds and skin defects, potentially paving the way for a new market for the the group.
Spray-on skin technology provider Avita Medical has won a contract extension aimed at helping a US biomedical research organisation prepare for treating burns from a nuclear explosion.
Perth-based regenerative medicine company Avita Medical says it will be able to focus more on its core ReCell technology after completing the sale of its respiratory business for $2.47 million.
Regenerative medicine company Avita Medical has raised $10 million from investors to support the commercialisation of its ReCell device, which is being trialled by a US government agency.
Fiona Wood-founded Avita Medical has received a $US16.9 million ($A24.1 million) commitment from a US government agency to fund a trial of its ReCell device.
